12:00 AM
 | 
May 24, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Coviracil emtricitabine: Phase I/II

HBV DNA levels decreased in all 44 patients after 56 days of treatment in a Phase I/II dose-escalation trial. Patients received up to 300...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >